Back
Zentalis Pharmaceuticals, Inc. Stock Price Chart
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
18
ZNTL
Zentalis Pharmaceuticals, Inc.
Last Price:
$1.40
Seasonality Move:
-19.35%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZNTL is experiencing selling pressure, which indicates risk of future bearish movement.
Zentalis Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.4 | Sell |
| 20-day SMA: | 1.36 | Buy |
| 50-day SMA: | 1.48 | Sell |
| 200-day SMA: | 1.49 | Sell |
| 8-day EMA: | 1.37 | Buy |
| 20-day EMA: | 1.15 | Buy |
| 50-day EMA: | 0.7 | Buy |
| 200-day EMA: | 0.23 | Buy |
Zentalis Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 48.2 | Sell |
| Chaikin Money Flow: | -393493 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.31 - 1.41) | Buy |
| Bollinger Bands (100): | (1.36 - 1.66) | Sell |
Zentalis Pharmaceuticals, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Zentalis Pharmaceuticals, Inc. Stock
Is Zentalis Pharmaceuticals, Inc. Stock a Buy?
-
Zentalis Pharmaceuticals, Inc. share price is 1.39 while ZNTL 8-day simple moving average is 1.40, which is a Sell signal.
-
The stock price of ZNTL is 1.39 while Zentalis Pharmaceuticals, Inc. 20-day SMA is 1.36, which makes it a Buy.
-
Zentalis Pharmaceuticals, Inc. 50-day simple moving average is 1.48 while ZNTL share price is 1.39, making it a Sell technically.
-
ZNTL stock price is 1.39 and Zentalis Pharmaceuticals, Inc. 200-day simple moving average is 1.49, creating a Sell signal.
ZNTL Technical Analysis vs Fundamental Analysis
Sell
18
Zentalis Pharmaceuticals, Inc. (ZNTL)
is a Sell
Is Zentalis Pharmaceuticals, Inc. a Buy or a Sell?
-
Zentalis Pharmaceuticals, Inc. stock is rated a SellThe current Zentalis Pharmaceuticals, Inc. [ZNTL] share price is $1.39. The Score for ZNTL is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Zentalis Pharmaceuticals, Inc. Stock Info
Market Cap:
100.4M
Price in USD:
1.39
Share Volume:
393.5K
Zentalis Pharmaceuticals, Inc. 52-Week Range
52-Week High:
4.00
52-Week Low:
1.01
Sell
18
Zentalis Pharmaceuticals, Inc. (ZNTL)
is a Sell
Zentalis Pharmaceuticals, Inc. Share Price Forecast
-
What is the Zentalis Pharmaceuticals, Inc. stock price today?The Zentalis Pharmaceuticals, Inc. stock price is 1.39 USD today.
-
Will ZNTL stock go up or go down?Zentalis Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Zentalis Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Zentalis Pharmaceuticals, Inc. is overvalued.
Is Zentalis Pharmaceuticals, Inc. Stock a Buy?
-
Zentalis Pharmaceuticals, Inc. share price is 1.39 while ZNTL 8-day exponential moving average is 1.37, which is a Buy signal.
-
The stock price of ZNTL is 1.39 while Zentalis Pharmaceuticals, Inc. 20-day EMA is 1.15, which makes it a Buy.
-
Zentalis Pharmaceuticals, Inc. 50-day exponential moving average is 0.70 while ZNTL share price is 1.39, making it a Buy technically.
-
ZNTL stock price is 1.39 and Zentalis Pharmaceuticals, Inc. 200-day simple moving average is 0.23, creating a Buy signal.
Fundamental Analysis of Zentalis Pharmaceuticals, Inc.
Is Zentalis Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.64 per share, and an increase next year of $0.16 per share.
Technical Analysis of Zentalis Pharmaceuticals, Inc.
Should I short Zentalis Pharmaceuticals, Inc. stock?
-
ZNTL Moving Average Covergence Divergence (MACD) indicator is 0.28, suggesting Zentalis Pharmaceuticals, Inc. is a Buy
-
Zentalis Pharmaceuticals, Inc. Relative Strength Index (RSI) is 48.2, which suggest Zentalis Pharmaceuticals, Inc. is oversold
-
The Bollinger Bands (25) for Zentalis Pharmaceuticals, Inc. is (1.31 - 1.41), which suggest Zentalis Pharmaceuticals, Inc. is a Sell
-
The Bollinger Bands (100) for Zentalis Pharmaceuticals, Inc. is (1.36 - 1.66), which suggest Zentalis Pharmaceuticals, Inc. is a Sell
* Zentalis Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.